Pneumocystis jirovecii
Pneumocystis jirovecii is a yeast-like fungus of the genus Pneumocystis. The causative organism of Pneumocystis pneumonia, it is an important human pathogen, particularly among immunocompromised hosts. Prior to its discovery as a human-specific pathogen, P. jirovecii was believed to be the same species as the Pneumocystis organisms that infect other mammals.
Overview[edit]
Pneumocystis is a genus of yeast-like fungus. In humans, it can cause a lung infection known as Pneumocystis pneumonia (PCP). Pneumocystis jirovecii is the most common species found in humans. It is an opportunistic pathogen, meaning it takes advantage of weakened immune systems to cause disease.
Infection and Disease[edit]
Infection with P. jirovecii can lead to PCP, a serious illness that can be fatal, especially in those with weakened immune systems. Symptoms of PCP include fever, cough, and difficulty breathing. The disease can be diagnosed through a variety of tests, including microscopy and polymerase chain reaction (PCR).
Treatment and Prevention[edit]
Treatment for PCP often involves medications such as trimethoprim-sulfamethoxazole (TMP-SMX), dapsone, and pentamidine. Prevention strategies include prophylactic therapy for those at high risk of infection.
Epidemiology[edit]
P. jirovecii is found worldwide. It is most commonly seen in people with weakened immune systems, such as those with HIV/AIDS, those undergoing chemotherapy, and organ transplant recipients.
History[edit]
The organism was first described in 1909 by Carlos Chagas, and was later named after Otto Jirovec, who documented its pathogenic potential in humans in the 1950s.
See Also[edit]
-
Pneumocystis jirovecii
-
Pneumocystis jirovecii
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
